Clinical Trial Update: "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients" [Phase 3]

View source ↗

Summary

Phase 3 trial investigating N-Acetylcysteine and psychotherapy for prodromal schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prodromal Schizophrenia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Prodromal Schizophrenia | Phase 3 | Status: TERMINATED